NASDAQ:HSDT Helius Medical Technologies (HSDT) Stock Price, News & Analysis $9.76 +1.17 (+13.55%) Closing price 04:00 PM EasternExtended Trading$9.46 -0.30 (-3.04%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Helius Medical Technologies Stock (NASDAQ:HSDT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HSDT alerts:Sign Up Key Stats Today's Range$8.30▼$9.9050-Day Range$8.60▼$240.5052-Week Range$8.21▼$1,200.00Volume206,961 shsAverage Volume35,148 shsMarket Capitalization$5.17 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania. Read More Helius Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreHSDT MarketRank™: Helius Medical Technologies scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Helius Medical Technologies.Read more about Helius Medical Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Helius Medical Technologies is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Helius Medical Technologies is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHelius Medical Technologies has a P/B Ratio of 2.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Helius Medical Technologies' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted540.42% of the float of Helius Medical Technologies has been sold short.Short Interest Ratio / Days to CoverHelius Medical Technologies has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Helius Medical Technologies has recently increased by 3,674.19%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHelius Medical Technologies does not currently pay a dividend.Dividend GrowthHelius Medical Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted540.42% of the float of Helius Medical Technologies has been sold short.Short Interest Ratio / Days to CoverHelius Medical Technologies has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Helius Medical Technologies has recently increased by 3,674.19%, indicating that investor sentiment is decreasing significantly. News and Social Media2.9 / 5News Sentiment0.14 News SentimentHelius Medical Technologies has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Helius Medical Technologies this week, compared to 1 article on an average week.Search Interest1 people have searched for HSDT on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Helius Medical Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders17.90% of the stock of Helius Medical Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 18.63% of the stock of Helius Medical Technologies is held by institutions.Read more about Helius Medical Technologies' insider trading history. Receive HSDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address HSDT Stock News HeadlinesHelius Medical Technologies Announces 1-for-50 Reverse Stock Split Effective June 30, 2025 - NasdaqJune 29 at 11:19 AM | nasdaq.comHelius Medical Technologies Announces Reverse Stock SplitJune 27, 2025 | globenewswire.comBanks aren’t ready for this altcoin—are you?In crypto, timing is everything. By the time the masses catch wind of this, the biggest gains could be ancient history. Are you ready to potentially change your financial future forever?July 2 at 2:00 AM | Crypto 101 Media (Ad)HSDT Helius Medical Technologies, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comHelius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) DeviceJune 16, 2025 | financialpost.comFHelius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) DeviceJune 16, 2025 | globenewswire.comHelius Medical Technologies, Inc.: Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual MeetingJune 13, 2025 | finanznachrichten.dePositive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual MeetingJune 12, 2025 | globenewswire.comSee More Headlines HSDT Stock Analysis - Frequently Asked Questions How have HSDT shares performed this year? Helius Medical Technologies' stock was trading at $502.7250 at the start of the year. Since then, HSDT shares have decreased by 98.1% and is now trading at $9.6150. View the best growth stocks for 2025 here. How were Helius Medical Technologies' earnings last quarter? Helius Medical Technologies, Inc. (NASDAQ:HSDT) released its quarterly earnings data on Thursday, May, 1st. The company reported ($25.50) earnings per share for the quarter, beating the consensus estimate of ($29.00) by $3.50. The firm earned $0.05 million during the quarter. Helius Medical Technologies had a negative net margin of 3,010.14% and a negative trailing twelve-month return on equity of 418.82%. When did Helius Medical Technologies' stock split? Helius Medical Technologies shares reverse split on Tuesday, July 1st 2025.The 1-50 reverse split was announced on Friday, June 27th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Helius Medical Technologies? Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Helius Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Helius Medical Technologies investors own include HubSpot (HUBS), Mazor Robotics (MZOR), Netflix (NFLX), Riot Platforms (RIOT), Tesla (TSLA), Acasti Pharma (ACST) and Company Calendar Last Earnings5/01/2025Today7/02/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:HSDT CIK1610853 Webheliusmedical.com Phone(877) 564-0008FaxN/AEmployees30Year Founded2014Profitability EPS (Trailing Twelve Months)($47.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.74 million Net Margins-3,010.14% Pretax Margin-3,010.14% Return on Equity-418.82% Return on Assets-243.54% Debt Debt-to-Equity RatioN/A Current Ratio1.69 Quick Ratio1.13 Sales & Book Value Annual Sales$520 thousand Price / Sales8.76 Cash FlowN/A Price / Cash FlowN/A Book Value$4.26 per share Price / Book2.02Miscellaneous Outstanding Shares530,000Free Float433,000Market Cap$4.56 million OptionableNot Optionable Beta0.87 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:HSDT) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helius Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.